[ad_1]
BioNTech and Pfizer, which supply the vaccine to European Union countries, say it will take 10 days to restore the significantly reduced supply of the vaccine to European countries. Due to this, in the next 4 weeks Lithuania will not receive 108,000 doses of the vaccine as planned, but half. The pharmaceutical giant justifies the delays due to changes in this vaccine plant in Belgium.
It is said that in order to produce the promised 2 billion doses per year, changes are needed in Belgium to increase production. Lithuania, Latvia, Estonia, Denmark, Sweden and Finland call these disorders “unacceptable”. A person needs two doses of the vaccine to be vaccinated, so a reduction in the supply, according to the ministers of health of 6 countries, puts the entire vaccination process at risk. At the request of the Baltic and Nordic countries, the European Commission immediately contacted the vaccine manufacturers.
“I immediately called the head of Pfizer and he explained that production would be delayed in the next few weeks, but he made sure that all guaranteed doses of the vaccine in the first quarter would be delivered in the first quarter,” said the Commission Chair. European, Ursula von der Leyen.
True, although it has promised to restore vaccine supplies within 10 days, Pfizer does not say how many and when the parties will receive the vaccines. Due to delays in vaccination, France is already preparing to review its vaccination strategy as a result. However, Norway, which is not a member of the European Union, has reduced its offer much less than Lithuania, only by a fifth. The party says the resulting vaccine shortage will be offset by its accumulated reserves for such situations. The UK will also get fewer Pfizer vaccines, but the country still promises to vaccinate 15 million people by mid-February. population.
[ad_2]
